DuPont Changing Labels For Antiseptic Products To Comply With FDA Warning
This article was originally published in The Tan Sheet
Executive Summary
DuPont plans by the end of June to comply with FDA's warning to change the labels for its RelyOn antiseptic spray and hand-wipe products that include disease claims not approved in a pending monograph for OTC health care antiseptics or in the topical antifungal drug products monograph
You may also be interested in...
FDA Budget Reaffirms Commitment To OTCs, Reduces Supplement Programs
FDA hopes to increase the number of over-the-counter drugs on the market as part of its long-term goal to provide consumers with safe, effective and affordable drugs, the agency states in its fiscal year 2007 budget request presentation
Antiseptic Products “Not Effective” In Reducing Skin Infection – FDA
No available evidence demonstrates that consumer antiseptic products reduce the risk of skin infection and such indications should not be included in the drug monograph, Office of Nonprescription Products reviewers say
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.